BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30616795)

  • 1. The impact of treatment package time on survival in surgically managed head and neck cancer in the United States.
    Goel AN; Frangos MI; Raghavan G; Lazaro SL; Tang B; Chhetri DK; Long JL; St John MA
    Oral Oncol; 2019 Jan; 88():39-48. PubMed ID: 30616795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer.
    Jacobs D; Torabi SJ; Park HS; Rahmati R; Young MR; Mehra S; Judson BL
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1240-1248. PubMed ID: 33198564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of surgery in multimodal treatment of oral and oropharyngeal cancer].
    Scheithauer MO; Riechelmann H
    Laryngorhinootologie; 2009 Feb; 88(2):101-5. PubMed ID: 18629755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
    Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
    Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach.
    Sadeghi N; Li NW; Taheri MR; Easley S; Siegel RS
    Head Neck; 2016 Dec; 38(12):1837-1846. PubMed ID: 27299983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynx.
    Díaz-Molina JP; Rodrigo JP; Alvarez-Marcos C; Blay P; de la Rúa A; Estrada E; Alonso R
    Acta Otorrinolaringol Esp; 2012; 63(5):348-54. PubMed ID: 22503508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological results after surgical treatment of squamous cell cancer of the lateral wall of the oropharynx.
    Díaz-Molina JP; Rodrigo JP; Alvarez-Marcos C; Llorente JL; Costales M; Suárez C
    Laryngoscope; 2011 Jul; 121(7):1449-54. PubMed ID: 21647899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?
    Yokota T; Onitsuka T; Kusafuka K; Ogawa H; Onozawa Y; Nakagawa M; Iida Y; Kamijo T; Nishimura T; Nakajima T; Boku N; Yasui H
    Int J Clin Oncol; 2014 Feb; 19(1):38-44. PubMed ID: 23463520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
    McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
    Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx.
    Walvekar RR; Li RJ; Gooding WE; Gibson MK; Heron D; Johnson JT; Ferris RL
    Laryngoscope; 2008 Dec; 118(12):2129-34. PubMed ID: 18948826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx.
    Moncrieff M; Sandilla J; Clark J; Clifford A; Shannon K; Gao K; O'Brien C
    Laryngoscope; 2009 Feb; 119(2):307-11. PubMed ID: 19172611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.